Literature DB >> 17954988

Prophylactic reoperation after mitral valve replacement with the Starr-Edwards ball valve: a report of four cases.

Akira Sezai1, Mitsumasa Hata, Tetsuya Niino, Masataka Yoda, Shinji Wakui, Tomofumi Umeda, Kazuma Shimura, Nobuyuki Furukawa, Kohtaroh Tokai, Yuji Kasamaki, Kazutomo Minami.   

Abstract

PURPOSE: The Starr-Edwards ball valve was first applied clinically in 1960. In our hospital, this valve has been used since 1963, and some patients have been followed up for 30 years or more. Based on our experience, therapeutic strategies included revalve replacement as a preventive procedure in the absence of valve-related complications. In this study, we investigated whether prophylactic reoperation after valve replacement with the Starr-Edwards ball valve is appropriate. PATIENTS AND METHODS: Of 58 patients in our institute who underwent mitral valve replacement with the Starr-Edwards ball valve, 12 underwent revalve replacement. Of these 12, the subjects of the present study were 4 patients who underwent prophylactic revalve replacement.
RESULTS: The mean postoperative follow-up of the 4 patients was 31.0+/-3.7 years. There were no operative deaths or postoperative complications. On examination of the extirpated Starr-Edwards valves, cloth wear was observed in all 4 patients. Although there was no influence on the range of ball motion, they showed the entity of "thrombus/pannus."
CONCLUSION: In this study, all of the patients showed cloth wear in the absence of complications. Therefore we consider that prophylactic reoperation after valve replacement with the Starr-Edwards valve should be performed to prevent complications.

Entities:  

Mesh:

Year:  2007        PMID: 17954988

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  4 in total

1.  Tissue-type plasminogen activator gene targets thrombolysis in atriums.

Authors:  Yongsheng Gong; Fajiu Wang; Xia Li; Zhixin Gao; Kailun Zhang; Chen Fan; Xingen Liu
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

2.  Starr-Edwards valves at the aortic and mitral positions implanted for 39 years.

Authors:  Shun-ichi Misawa; Kei Aizawa; Yuichiro Kaminishi; Arata Muraoka; Yoshio Misawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

3.  Paraprosthetic leak closure 28 years after mitral caged-ball Starr-Edwards implantation.

Authors:  Karolina Antończyk; Lech Paluszkiewicz; Heinrich Koertke; Jan Gummert
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-04-18

4.  A case of the Starr-Edwards ball valve (Model 6120) in the mitral position for 45 years.

Authors:  Shuhei Azuma; Masafumi Morita; Yasuhiro Yoshii; Shigetoshi Mieno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.